NIOSH has released an updated list of hazardous drugs for healthcare workers, incorporating 25 new drugs and removing seven.

TEVAN.UL] failed to convince a U.S. appeals court on Friday to reverse a decision that would remove patents related to its ...

The weight loss medication tirzepatide (Mounjaro and Zepbound) is no longer in shortage, according to the FDA. Access to ...

The U.S. Food and Drug Administration on Monday approved Hikma Pharmaceuticals' generic version of Novo Nordisk's diabetes ...

Diabetes drug Victoza, or liraglutide, is a first generation GLP-1, a class of treatments that has seen overwhelming demand. It has been on the FDA’s shortage list since 2023, and currently ...

The FDA has approved the first generic form of liraglutide (Victoza), a once-daily injectable for improving glycemic control ...

The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced ...

From pig kidney transplants to the development of a new schizophrenia drug, here are five of the biggest medical ...

Neither drug is considered as effective as the brand ... requiring treatment for type 2 diabetes," Cody Stanford said. The list price for Ozempic and Mounjaro each run more than $1,000 a month ...

India is developing a framework for over-the-counter (OTC) drugs, potentially allowing some prescription medications to be sold in general stores. A sub-committee is reviewing international guidelines ...

On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a Declaratory Order reevaluating and re-confirming ...

Attempts to restrict pharmaceutical advertisements have failed many times over the years, often on First Amendment grounds.